Companies

Dr Reddy’s launches generic version of Librax in US

Our Bureau Hyderabad | Updated on August 31, 2021

Brings out chlordiazepoxide hydrochloride and clidinium bromide capsules

Pharma major Dr Reddy’s Laboratories Ltd has launched chlordiazepoxide hydrochloride and clidinium bromide capsules, a therapeutic equivalent generic version of Librax (chlordiazepoxide hydrochloride and clidinium bromide) approved by the US Food and Drug Administration (USFDA).

The Librax® brand and generic market had US sales of approximately $105.9 million for the most recent twelve months ending in July 2021, according to IQVIA Health.

Hyderabad-based Dr Reddy’s chlordiazepoxide hydrochloride and clidinium bromide capsules, USP are available in one strength of 5mg/2.5mg capsules in bottle count sizes of 100, the company said in a release.

Published on August 31, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like